Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cox-2-Inhibitor and Chemotherapy in Non-Small Cell Lung Cancer. A Prospective Randomized Double-Blind Study

NCT00300729 is registered in ClinicalTrials.gov with University Hospital, Linkoeping as lead sponsor.

NCT NCT00300729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00300729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cox-2-Inhibitor and Chemotherapy in Non-Small Cell Lung Cancer. A Prospective Randomized Double-Blind Study
Lead sponsor
University Hospital, Linkoeping
Phase
Phase 3
Overall status
Unknown status
Start date
May 31, 2006
Completion date
September 30, 2010
Enrollment
319 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer